Literature DB >> 11701272

High-dose vitamin B(6) treatment in West syndrome.

Y Toribe1.   

Abstract

Approximately 10-30% of patients with West syndrome respond to high-dose vitamin B(6) treatment. The response to vitamin B(6) is rapid; seizures disappear within the first 2 weeks of treatment. Mild side effects, such as gastrointestinal symptoms and liver dysfunction, are observed in 40-70%, but these resolve after discontinuation or a reduction of the dosage of vitamin B(6). High-dose vitamin B(6) treatment is useful as a first line agent in treating West syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701272     DOI: 10.1016/s0387-7604(01)00292-3

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  5 in total

1.  Clinical characteristics of two cohorts of infantile spasms: response to pyridoxine or topiramate monotherapy.

Authors:  Jiao Xue; Ping Qian; Hui Li; Ye Wu; Hui Xiong; Yue-Hua Zhang; Zhi-Xian Yang
Journal:  World J Pediatr       Date:  2018-04-26       Impact factor: 2.764

Review 2.  Infantile spasms: review of the literature and personal experience.

Authors:  Alberto Fois
Journal:  Ital J Pediatr       Date:  2010-02-08       Impact factor: 2.638

3.  The Clinical Features and Long-Term Follow-Up of Vitamin B6-Responsive Infantile Spasms in a Chinese Cohort.

Authors:  Xianru Jiao; Pan Gong; Yue Niu; Zhao Xu; Ye Wu; Yuehua Zhang; Zhixian Yang
Journal:  Front Neurol       Date:  2022-05-12       Impact factor: 4.086

4.  Topiramate and adrenocorticotropic hormone (ACTH) as initial treatment for infantile spasms.

Authors:  Bradley Peltzer; William D Alonso; Brenda E Porter
Journal:  J Child Neurol       Date:  2009-02-18       Impact factor: 1.987

5.  PLPBP mutations cause variable phenotypes of developmental and epileptic encephalopathy.

Authors:  Hiroshi Shiraku; Mitsuko Nakashima; Saoko Takeshita; Chai-Soon Khoo; Muzhirah Haniffa; Gaik-Siew Ch'ng; Kazuma Takada; Keisuke Nakajima; Masayasu Ohta; Tohru Okanishi; Sotaro Kanai; Ayataka Fujimoto; Hirotomo Saitsu; Naomichi Matsumoto; Mitsuhiro Kato
Journal:  Epilepsia Open       Date:  2018-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.